How We Collaborate
Ideally, our collaboration starts at the earliest stages of product conception and company formation. This may be at the time of idea generation or after patents have been filed and the company is in the process of raising seed capital. After a rigorous assessment of the opportunity is performed, a meeting is scheduled with our technical team to discuss product design, technical and material requirements, project consulting, intellectual property, and regulatory strategies in order to understand what is feasible and what is not. We ask the right questions from the start to get you on the right track in order to streamline the research and development process, improve capital efficiency, and minimize risk.
Once an R&D plan is developed, our technical team can either collaborate with your team or take the reins by overseeing project management, device design, quality control and device manufacturing so that you can focus on commercialization. Rather than incurring costly expenditures for equipment and overhead to get started, we have the resources and infrastructure to get your company off the ground so that capital efficiency is assured through proof of concept. We also provide seed financing to cover these costs as well as a place to “house” your company while your company meets necessary milestones for future funding.
Not only do we work with our portfolio companies on product development, we assist with marketing, regulatory, reimbursement, and fund raising strategies as well as in the recruitment of key management. Our extensive network in the life sciences which includes major corporations, angel groups and the venture community gives our portfolio companies the exposure that they need to sources of capital, strategic partnering, licensing opportunities and early exits through acquisition.
Investment Criteria
We believe that the ideal investment opportunity is a polymer intensive product or technology that meets the following criteria:
• Proprietary technology that addresses large markets
• Technology that requires an advanced polymer material or component
• Product still in conceptual phase before initiation of preclinical research
• Technology where we can add “value” (deep expertise, IP, R&D strength, quality systems, ISO
certified and FDA compliant cleanroom)
• Clear regulatory and reimbursement pathway
• Due diligence validation
• A technical and/or management team in place with a successful track record with start-ups
• Seed or early investment opportunity
• Potential for early exit (36-48 months)